Metastatic Colorectal Cancer (CRC)

Oncology·MeSH: Colorectal Neoplasms

Prevalence

135.0 / 100K

Incidence

36.0 / 100K/yr

4 drugs in development·4 companies·6 clinical trials

Drug Pipeline by Phase

Compare drugs

krazati vs Drugkrazati vs Fruquintinib Combined With Chemotherapykrazati vs Vincristine Sulfate Liposome

Frequently asked questions

How many drugs are in development for Metastatic Colorectal Cancer (CRC)?

BioSniper tracks 4 drugs in development for Metastatic Colorectal Cancer (CRC) across 4 companies.

How many clinical trials target Metastatic Colorectal Cancer (CRC)?

There are 6 clinical trials targeting Metastatic Colorectal Cancer (CRC) tracked by BioSniper.

What is the prevalence of Metastatic Colorectal Cancer (CRC)?

The estimated prevalence of Metastatic Colorectal Cancer (CRC) is approximately 135.0 per 100,000 population.

Deep-dive into Metastatic Colorectal Cancer (CRC)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Metastatic Colorectal Cancer (CRC) — Drugs in Development & Clinical Trials | BioSniper